Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disorders CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...

Blue Chip Patient Recruitment Launches Digital Media Survey NORTHBROOK, IL--(Marketwire - January 18, 2011) - Blue Chip Patient Recruitment (BCPR), a division of global, full-service marketing agency Blue Chip Marketing Worldwide, announced today the launch of...